• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏磁共振体素内不相干运动技术评估肥厚型心肌病微循环功能障碍的价值。

The Value of the Cardiac Magnetic Resonance Intravoxel Incoherent Motion Technique in Evaluating Microcirculatory Dysfunction in Hypertrophic Cardiomyopathy.

机构信息

Department of Imaging, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, China.

MR Scientific Marketing, Siemens Healthineers, Shanghai 201318, China.

出版信息

J Interv Cardiol. 2023 Jun 28;2023:4611602. doi: 10.1155/2023/4611602. eCollection 2023.

DOI:10.1155/2023/4611602
PMID:37415784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10322278/
Abstract

OBJECTIVE

To evaluate the value of the cardiac magnetic resonance intravoxel incoherent motion (IVIM) technique in microcirculatory dysfunction in patients with hypertrophic cardiomyopathy (HCM).

METHODS

The medical records of 19 patients with HCM in our hospital from January 2020 to May 2021 were collected retrospectively, and 23 healthy people with a similar age and gender distribution to the patients with HCM were included as controls. All the included subjects underwent clinical assessment and cardiac magnetic resonance imaging. The original IVIM images were analysed, and the imaging parameters of each segment were measured. The HCM group was divided into non-hypertrophic myocardium and hypertrophic myocardium groups. The differences in imaging parameters between the normal and HCM groups were compared. A Spearman correlation analysis was used to explore the correlation between end-diastolic thickness (EDTH) and each IVIM parameter.

RESULTS

The D and f values in the HCM group were lower than those in the normal group ( < 0.0001 and = 0.004, respectively). The f, D, D, and EDTH values of the hypertrophic segment, non-hypertrophic segment, and normal groups were statistically significant ( < 0.05). The difference in D values among the mild, moderate, severe, and very severe HCM groups was statistically significant ( < 0.05). There was a statistically significant difference in EDTH among the mild, moderate, severe, and very severe groups ( < 0.001). There were significant differences in the values of D, D, and f between the non-delayed enhancement group and the delayed enhancement group ( < 0.05). The EDTH values of 304 segments in the HCM group were negatively correlated with f ( = -0.219, = 0.028) and D values ( = -0.310, < 0.001).

CONCLUSION

The use of IVIM technology can achieve a non-invasive early quantitative assessment of microvascular disease in HCM without the injection of a contrast agent and provide a reference for the early diagnosis of and intervention in myocardial ischemia in patients with HCM.

摘要

目的

评估心脏磁共振体素内不相干运动(IVIM)技术在肥厚型心肌病(HCM)患者微循环功能障碍中的价值。

方法

回顾性收集 2020 年 1 月至 2021 年 5 月我院 19 例 HCM 患者的病历资料,纳入与 HCM 患者年龄和性别分布相匹配的 23 例健康人作为对照组。所有纳入对象均进行临床评估和心脏磁共振成像检查。对原始 IVIM 图像进行分析,并测量各节段的成像参数。将 HCM 组分为非肥厚心肌组和肥厚心肌组,比较正常组和 HCM 组的影像学参数差异。采用 Spearman 相关分析探讨舒张末期厚度(EDTH)与各 IVIM 参数的相关性。

结果

HCM 组的 D 值和 f 值均低于正常组(均<0.0001, = 0.004)。肥厚节段、非肥厚节段和正常组的 f、D、D和 EDTH 值比较差异均有统计学意义(均<0.05)。HCM 组轻度、中度、重度和极重度组间 D 值比较差异均有统计学意义(均<0.05)。HCM 组的 EDTH 值在轻度、中度、重度和极重度组间比较差异均有统计学意义(均<0.001)。非延迟强化组与延迟强化组的 D、D和 f 值比较差异均有统计学意义(均<0.05)。HCM 组 304 个节段的 EDTH 值与 f 值( = -0.219, = 0.028)和 D 值( = -0.310, < 0.001)呈负相关。

结论

使用 IVIM 技术无需注射造影剂即可实现对 HCM 微血管疾病的无创早期定量评估,为 HCM 患者心肌缺血的早期诊断和干预提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa0/10322278/df25c648dc55/JITC2023-4611602.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa0/10322278/310a79281933/JITC2023-4611602.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa0/10322278/df25c648dc55/JITC2023-4611602.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa0/10322278/310a79281933/JITC2023-4611602.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa0/10322278/df25c648dc55/JITC2023-4611602.002.jpg

相似文献

1
The Value of the Cardiac Magnetic Resonance Intravoxel Incoherent Motion Technique in Evaluating Microcirculatory Dysfunction in Hypertrophic Cardiomyopathy.心脏磁共振体素内不相干运动技术评估肥厚型心肌病微循环功能障碍的价值。
J Interv Cardiol. 2023 Jun 28;2023:4611602. doi: 10.1155/2023/4611602. eCollection 2023.
2
3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.3.0 T磁共振心肌灌注成像用于肥厚型心肌病冠状动脉微血管功能障碍的半定量评估
Int J Cardiovasc Imaging. 2017 Dec;33(12):1949-1959. doi: 10.1007/s10554-017-1189-9. Epub 2017 Jun 13.
3
Microvascular Dysfunction Associates With Outcomes in Hypertrophic Cardiomyopathy: Insights From the Intravoxel Incoherent Motion MRI.微血管功能障碍与肥厚型心肌病的预后相关:来自体素内不相干运动 MRI 的观察。
J Magn Reson Imaging. 2023 Jun;57(6):1766-1775. doi: 10.1002/jmri.28450. Epub 2022 Oct 6.
4
Assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: first-pass myocardial perfusion cardiovascular magnetic resonance imaging at 1.5 T.肥厚型心肌病患者冠状动脉微血管功能障碍的评估:1.5T 首过心肌灌注心血管磁共振成像。
Clin Radiol. 2013 Jul;68(7):676-82. doi: 10.1016/j.crad.2013.01.003. Epub 2013 Apr 6.
5
MRI native T1 and T2 mapping of myocardial segments in hypertrophic cardiomyopathy: tissue remodeling manifested prior to structure changes.MRI 心肌节段 native T1 和 T2 mapping 在肥厚型心肌病中的应用:结构改变前的组织重构表现。
Br J Radiol. 2019 Dec;92(1104):20190634. doi: 10.1259/bjr.20190634. Epub 2019 Oct 16.
6
The feasibility and diagnostic value of intravoxel incoherent motion diffusion-weighted imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy patients.探讨体素内不相干运动扩散加权成像评估肥厚型心肌病患者心肌纤维化的可行性及诊断价值。
Eur J Radiol. 2020 Nov;132:109333. doi: 10.1016/j.ejrad.2020.109333. Epub 2020 Oct 7.
7
Diastolic dysfunction assessed by cardiac magnetic resonance imaging tissue tracking on normal-thickness wall segments in hypertrophic cardiomyopathy.肥厚型心肌病正常壁段心肌磁共振组织追踪技术评估舒张功能障碍。
BMC Med Imaging. 2023 Jan 10;23(1):7. doi: 10.1186/s12880-022-00955-7.
8
Noncontrast T1ρ dispersion imaging is sensitive to diffuse fibrosis: A cardiovascular magnetic resonance study at 3T in hypertrophic cardiomyopathy.非对比 T1ρ 弥散成像对弥漫性纤维化敏感:肥厚型心肌病的 3T 心血管磁共振研究。
Magn Reson Imaging. 2022 Sep;91:1-8. doi: 10.1016/j.mri.2022.05.001. Epub 2022 May 4.
9
Myocardium microcirculation study in a healthy Chinese population using 3.0-T cardiac magnetic resonance intravoxel incoherent motion imaging.采用 3.0T 心脏磁共振体素内不相干运动成像技术研究健康中国人群的心肌微循环。
Acta Radiol. 2022 May;63(5):596-605. doi: 10.1177/02841851211006311. Epub 2021 Apr 22.
10
The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.肥厚型心肌病伴或不伴左心室流出道梗阻患者的局部心肌微血管功能障碍差异:使用3.0-T心脏磁共振首次通过灌注成像进行评估
Eur J Radiol. 2014 Apr;83(4):665-72. doi: 10.1016/j.ejrad.2014.01.008. Epub 2014 Jan 16.

引用本文的文献

1
Myocardial injury in Duchenne muscular dystrophy: assessment via cardiac magnetic resonance intra-voxel incoherent motion.杜氏肌营养不良症中的心肌损伤:通过心脏磁共振体素内不相干运动进行评估。
Heart Vessels. 2025 Jul 21. doi: 10.1007/s00380-025-02580-0.
2
Recent Progress of Cardiac MRI for Nuclear Medicine Professionals.核医学专业人员的心脏磁共振成像最新进展
Nucl Med Mol Imaging. 2024 Dec;58(7):431-448. doi: 10.1007/s13139-024-00850-9. Epub 2024 Feb 14.

本文引用的文献

1
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 年美国心脏病学会/美国心脏协会肥厚型心肌病诊断和治疗指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会的报告。
Circulation. 2020 Dec 22;142(25):e533-e557. doi: 10.1161/CIR.0000000000000938. Epub 2020 Nov 20.
2
Coronary Microvascular Dysfunction and the Role of Noninvasive Cardiovascular Imaging.冠状动脉微血管功能障碍与无创心血管成像的作用
Diagnostics (Basel). 2020 Sep 9;10(9):679. doi: 10.3390/diagnostics10090679.
3
Coronary microvascular dysfunction in hypertrophic cardiomyopathy: Pathophysiology, assessment, and clinical impact.
肥厚型心肌病中的冠状动脉微血管功能障碍:病理生理学、评估和临床影响。
Microcirculation. 2021 Jan;28(1):e12656. doi: 10.1111/micc.12656. Epub 2020 Sep 22.
4
Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.直线灌流绘图提供了对肥厚型心肌病发病机制的深入了解。
Heart. 2020 Jun;106(11):824-829. doi: 10.1136/heartjnl-2019-315848. Epub 2019 Dec 10.
5
Coronary Microvascular Dysfunction: Clinical Considerations and Noninvasive Diagnosis.冠状动脉微血管功能障碍:临床注意事项与无创诊断。
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):140-155. doi: 10.1016/j.jcmg.2018.11.036. Epub 2019 Apr 12.
6
Cardiology: hypertrophic cardiomyopathy.心脏病学:肥厚型心肌病。
Clin Med (Lond). 2019 Jan;19(1):61-63. doi: 10.7861/clinmedicine.19-1-61.
7
STROBE-A preliminary investigation of IVIM-DWI in cardiac imaging.STROBE-心脏成像中体素内不相干运动扩散加权成像的初步研究。
Medicine (Baltimore). 2018 Sep;97(36):e11902. doi: 10.1097/MD.0000000000011902.
8
Clinical Course and Management of Hypertrophic Cardiomyopathy.肥厚型心肌病的临床病程与管理
N Engl J Med. 2018 Aug 16;379(7):655-668. doi: 10.1056/NEJMra1710575.
9
Diagnostic performance of intravoxel incoherent motion diffusion-weighted imaging in the assessment of the dynamic status of myocardial perfusion.磁共振体素内不相干运动扩散加权成像评估心肌灌注的动态状态的诊断性能。
J Magn Reson Imaging. 2018 Dec;48(6):1602-1609. doi: 10.1002/jmri.26179. Epub 2018 May 7.
10
Myocardial stress perfusion magnetic resonance in children with hypertrophic cardiomyopathy.肥厚型心肌病患儿的心肌应力灌注磁共振成像
Cardiol Young. 2018 May;28(5):702-708. doi: 10.1017/S1047951118000094.